Shapei Yan

460 total citations
25 papers, 297 citations indexed

About

Shapei Yan is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Shapei Yan has authored 25 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 14 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Shapei Yan's work include Opioid Use Disorder Treatment (20 papers), Substance Abuse Treatment and Outcomes (12 papers) and Prenatal Substance Exposure Effects (8 papers). Shapei Yan is often cited by papers focused on Opioid Use Disorder Treatment (20 papers), Substance Abuse Treatment and Outcomes (12 papers) and Prenatal Substance Exposure Effects (8 papers). Shapei Yan collaborates with scholars based in United States, United Kingdom and Taiwan. Shapei Yan's co-authors include Zhaoxia Qu, Alexander Y. Walley, Marc R. Larochelle, Guozhi Xiao, Traci C. Green, Steven D. Shapiro, Jingbin Zhou, J. A. Whitsett, Ziming Xuan and Fei Sun and has published in prestigious journals such as PEDIATRICS, Oncogene and Journal of General Internal Medicine.

In The Last Decade

Shapei Yan

20 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shapei Yan United States 10 152 85 75 58 46 25 297
Jessica Ma United States 9 172 1.1× 63 0.7× 56 0.7× 55 0.9× 97 2.1× 53 440
Neeraj Chhabra United States 9 81 0.5× 40 0.5× 77 1.0× 31 0.5× 30 0.7× 37 285
Kristine Torres‐Lockhart United States 6 105 0.7× 72 0.8× 27 0.4× 5 0.1× 47 1.0× 12 179
Ebony Dix United States 8 120 0.8× 68 0.8× 47 0.6× 68 1.2× 16 0.3× 22 318
Wenwu Cheng China 11 158 1.0× 27 0.3× 82 1.1× 13 0.2× 53 1.2× 24 310
Luca Manfredini Italy 11 71 0.5× 71 0.8× 55 0.7× 36 0.6× 19 0.4× 24 308
Nicola Perlman United States 9 120 0.8× 16 0.2× 106 1.4× 133 2.3× 42 0.9× 11 395
Valerie Angus United Kingdom 4 261 1.7× 59 0.7× 91 1.2× 12 0.2× 12 0.3× 6 460
Su Jin Koh South Korea 11 192 1.3× 9 0.1× 38 0.5× 5 0.1× 46 1.0× 15 323
Paulina Krawiec Poland 12 33 0.2× 37 0.4× 10 0.1× 43 0.7× 48 1.0× 32 297

Countries citing papers authored by Shapei Yan

Since Specialization
Citations

This map shows the geographic impact of Shapei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shapei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shapei Yan more than expected).

Fields of papers citing papers by Shapei Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shapei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shapei Yan. The network helps show where Shapei Yan may publish in the future.

Co-authorship network of co-authors of Shapei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Shapei Yan. A scholar is included among the top collaborators of Shapei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shapei Yan. Shapei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadland, Scott E., Simeon D. Kimmel, Shapei Yan, et al.. (2025). Buprenorphine Treatment Duration and Adherence Among Youth and Subsequent Health Outcomes. PEDIATRICS. 156(6).
2.
3.
McCann, Nicole C., et al.. (2025). Test-Retest Reliability of a Timeline Follow-back Method to Assess Opioid Use and Treatment. Journal of Addiction Medicine. 19(5). 565–569.
4.
Xuan, Ziming, et al.. (2024). Pharmacy Naloxone Standing Order and Community Opioid Fatality Rates Over Time. JAMA Network Open. 7(8). e2427236–e2427236. 3 indexed citations
5.
Rosenmoss, Sophie, Marc R. Larochelle, Benjamin Bearnot, et al.. (2024). Racial and Ethnic Disparities in Referral Rejection From Postacute Care Facilities Among People With Opioid Use Disorder in Massachusetts. Journal of Addiction Medicine. 19(2). 165–171.
6.
Kimmel, Simeon D., Alexander Y. Walley, Laura F. White, et al.. (2024). Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts. JAMA Network Open. 7(7). e2421740–e2421740. 2 indexed citations
7.
8.
Bagley, Sarah M., Leo Beletsky, Traci C. Green, et al.. (2024). Privacy and confidentiality in Massachusetts' post-overdose outreach programs: Mixed methods analysis of outreach staff surveys and interviews. International Journal of Drug Policy. 124. 104310–104310. 1 indexed citations
9.
Schoenberger, Samantha F., Jennifer Carroll, Shapei Yan, et al.. (2024). “Wanna cry this out real quick?”: an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts. Harm Reduction Journal. 21(1). 66–66. 1 indexed citations
10.
Xuan, Ziming, Shapei Yan, Traci C. Green, et al.. (2023). Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities. JAMA Psychiatry. 80(5). 468–468. 16 indexed citations
11.
Kimmel, Simeon D., Ziming Xuan, Shapei Yan, et al.. (2023). Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts. International Journal of Drug Policy. 120. 104164–104164. 4 indexed citations
12.
Chatterjee, Avik, Shapei Yan, Jake R. Morgan, et al.. (2023). Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019. Health Services Research. 58(5). 1141–1150. 3 indexed citations
13.
Zang, Xiao, Avik Chatterjee, Czarina N. Behrends, et al.. (2021). Community‐based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 117(5). 1372–1381. 12 indexed citations
14.
Larochelle, Marc R., Ricardo Cruz, Daniel P. Alford, et al.. (2021). Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?. Journal of General Internal Medicine. 37(10). 2365–2372. 5 indexed citations
15.
Chatterjee, Avik, Shapei Yan, Ziming Xuan, et al.. (2021). Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug and Alcohol Dependence. 230. 109190–109190. 20 indexed citations
16.
Tori, Marco, Leo Beletsky, Samantha F. Schoenberger, et al.. (2021). Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study. International Journal of Drug Policy. 100. 103483–103483. 17 indexed citations
17.
Waye, Katherine M., Shapei Yan, Sarah M. Bagley, et al.. (2020). Characteristics of post-overdose public health-public safety outreach in Massachusetts. Drug and Alcohol Dependence. 219. 108499–108499. 26 indexed citations
18.
Zhao, Yihong, et al.. (2020). Opioid Prescribing Patterns Among Oral and Maxillofacial Surgeons: A Regional Survey-Based Study. Journal of Oral and Maxillofacial Surgery. 78(7). 1078–1087. 4 indexed citations
19.
Zhou, Jingjiao, Zhaoxia Qu, Fan Sun, et al.. (2017). Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation. Cancer Immunology Research. 5(3). 257–268. 60 indexed citations
20.
Zhou, Jingbin, Zhaoxia Qu, Shapei Yan, et al.. (2014). Differential roles of STAT3 in the initiation and growth of lung cancer. Oncogene. 34(29). 3804–3814. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Ma Breakdown of academic impact, for papers by Neeraj Chhabra Breakdown of academic impact, for papers by Kristine Torres‐Lockhart Breakdown of academic impact, for papers by Ebony Dix Breakdown of academic impact, for papers by Wenwu Cheng Breakdown of academic impact, for papers by Luca Manfredini Breakdown of academic impact, for papers by Nicola Perlman Breakdown of academic impact, for papers by Valerie Angus Breakdown of academic impact, for papers by Su Jin Koh Breakdown of academic impact, for papers by Paulina Krawiec
Rankless by CCL
2026